Abstract. [6,7-3H] Estrone (E) and [6,7-3H]estradiol-17fl (E2) have been synthesized by reduction of 6-dehydroestrone and 6-dehydroestradiol with tritium gas. Tritiated E and E2 were administered by oral gavage to female rats and to male and female hamsters on a dose level of about 300 ~tg/kg (54 mCi/kg). After 8 h, the liver was excised from the rats; liver and kidneys were taken from the hamsters. DNA was purified either directly from an organ homogenate or via chromatin. The radioactivity in the DNA was expressed in the units of the Covalent Binding Index, CBI = (~tmol chemical bound per mol DNA-P)/(mmol chemical administered per kg b.w.). Rat liver DNA isolated via chromatin exhibited the very low values of 0.08 and 0.09 for E and E2, respectively. The respective figures in hamster liver were 0.08 and 0.11 in females and 0.21 and 0.18 in the males. DNA isolated from the kidney revealed a detectable radioactivity only in the female, with values of 0.03 and 0.05 for E and E2, respectively. The values for male hamster kidney were < 0.01 for both hormones. The minute radioactivity detectable in the DNA samples does not represent covalent binding to DNA, however, as indicated by' two sets of control experiments. (A) Analysis by HPLC of the nucleosides prepared by enzyme digest of liver DNA isolated directly or via chromatin did not reveal any consistent peak which could have been attributed to a nucleoside-steroid adduct. (B) All DNA radioactivity could be due to protein contaminations, because the specific activity of chromatin protein was determined to be more than 3,000 times higher than of DNA. The high affinity of the hormone to protein was also demonstrated by in vitro incubations, where it could be shown that the specific activity of DNA and protein was essentially proportional to the concentration of radiolabelled hormone in the organ homogenate, regardless of whether the animal was treated or whether the hormone was added in vitro to the homogenate.
Introduction
Although there is no doubt about the importance of steroid estrogen hormones in carcinogenesis (IARC 1974 (IARC , 1979 , the mechanism of action is under debate. Three possibilities are being discussed, (i) a covalent binding of chemically reactive metabolites to DNA (Blackburn et al. 1977; Bolt and Kappus 1974; Jaggi et al. 1978; Pelkonen et al. 1978; Tsibris and McGuire 1977) , (ii) the generation of DNA-damaging oxygen species generated during catechol-quinone oxidation processes (Cerutti 1978; Mitchell et al. 1982) , and (iii) non-genotoxic mechanisms involving some aspect of the hormonal activity (Cameron et al. 1982; Henderson et al. 1982; Weisburger and Williams 1981; Yager and Yager 1980) . It is also possible that the effect observed is a result of a combination of the various single activities, each of which having a different relative weight in different target cell types.
This laboratory has been involved in attempts to quantify the covalent DNA binding of various chemical carcinogens (Lutz 1979) , and a correlation of tumorigenic vs. DNA-binding potencies in vivo (Lutz 1982) seems to allow to assess whether a given hepato-carcinogenicity in the rat can be based upon DNA binding or whether other mechanism are more likely to be responsible Sagelsdorff et al. 1983) .
In 1978, we reported on non-extractable radioactivity on liver DNA of rats treated with tritiated ethinylestradiol (EE) and estrone (E). Although the apparent binding potency was as much as 104 times lower than that of aflatoxin B t the data indicated that a minute genotoxicity of these estrogens mediated by DNA binding in vivo could not be excluded (Jaggi et al. 1978) . The experimental techniques available at that time did not allow, however, the definite proof of a DNA-hormone adduct on such a low level of binding. With semi-preparative HPLC methods becoming available, we have taken up this line again, essentially in the search for endogenous DNA damage. We therefore radiosynthesized [3H] estrone (E) and [3H]estradiol (E2), administered up to 10 mCi [3H] to rats and hamsters and purified DNA from livers and kidneys by different procedures known to produce a DNA with varying degrees of protein contamination. Enzymatic hydrolysis of the samples to deoxyribonucleosides was performed to investigate whether the radioactivity which was measurable in all samples could be due to a nucleoside-estrogen adduct.
Materials and methods
Chemicals and materials. 3, 5, (10) ,6-estratetraen-3,17fl-diol) and 6-dehydroestrone (1,3,5,(10),6-estratetraen-3-ol,17-one) were purchased from Research Plus Steroid, Denville, NJ. Carrier-free tritium gas was from The Radiochemical Centre, Amersham, England. L- [4,5-3H(N) ]Lysine with a specific activity of 74.6 Ci/mmol was from New England Nuclear, Boston, MA. Copper oxide (wire form) and palladium/coal (10%) catalyst were from Fluka, Buchs, Switzerland, and tlc-alu-silicagel-60 plates with concentrating area, were from Merck, Darmstadt, FRG. Nonidet P 40 (NP 40) was from BDH Chemicals, Poole, England; Hydroxylapatite (HA) DNA-Grade Bio-Gel HTP was from Bio Rad, Richmond CA; Dialysis tubing (Viking type 20/32 molecular weight exclusion 12,000-14,000 Daltons) was from Union Carbide, Chicago, IL. Deoxyribonuclease I (E.C. 3.1.4.5) from bovine pancreas, phosphodiesterase I (E.C. 3.1.4.1) from crotalus atrox venom, alkaline phosphatase III (E.C. 3.1.3.1) from Escherichia coli, reference nucleosides and reference hormones were from Sigma, St. Louis, MO. All other chemicals were from Merck, Darmstadt, FRG, or from Fluka, Buchs, Switzerland, and were of analytical grade. [6, 7-3H] estrone (E) and [6, 7-3H] 
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estradiol (E2). E
and E2 were radiosynthesized by reducing a mixture of 6-dehydroestrone (0.093 mmol) and 6-dehydroestradiol (0.070 mmol) according to Merrill and Vernice (1970) with 0.149 mmol carrier-free tritium gas in 2 ml ethyl acetate containing 31.5 mg 10% Pd/C catalyst in a 10 ml round-bottom flask for 2 h at 20 ~ C on a high vacuum line. The remaining educt was reduced with hydrogen gas, the unreacted tritium/hydrogen mixture was combusted over copper oxide at about 500 ~ C and lyophilized into a break-seal ampoule. The reaction yielded 25.2 mg (0.093 retool) E and 19.0 mg (0.070 mmol) E2, with a specific activity of 48 Ci/mmol. Identity was checked by thin-layer-chromatography and by cocristallization with unlabelled hormones. Immediately before use, the radiolabelled hormones were purified by 2-dimensional thin-layer-chromatography on silica gel with dichloromethane : ethanol (100 : 7.5) used for the first dimension. The Rv values were 3.57 and 0.43 for E and E2, respectively. The appropiate strips ~r cut out and developed with ethanol (Rr = 1.0 for both hormones). The hormones were eluted from the spots with ethanol and stored overnight at 4 ~ C. The radiochemical purity 0vas determined 1 h before administration to the animals and was always better than 98%. homogenizing the liver in three volumes 75 mM NaC1, 10 mM EDTA, 10 mM Tris/HCl pH 7.8 in a Potter-Elvehjem-type teflon homogenizer and precipitation with the non-ionic detergent NP 40 according to Yaneva and Dessev (1976) . This pellet contained about 2-3 mg DNA and 20-30 mg protein per gram liver and was blended in lysing medium. The further purification of the DNA from a) and b) followed the standard method used in our laboratory (Sagelsdorff et al. 1983) which is based on a deproteination with phenol : chloroform : isoamyl alcohol (PCI) and extensive washing after adsorption to a hydroxylapatite column. After desorption with high ionic strength (0.48 M in phosphate) and dialysis against 0.2 M sodium chloride, DNA was precipitated with two volumes of ethanol, stored overnight at -20~ dried on aspirator vacuum and dissolved in 10 mM MgClz, 10 mM Tris buffer pH 7.0. The amount of DNA was determined on the basis of an absorbance of 20 for a solution of i mg/ml (Viviani and Lutz 1978 ). An aliquot of the DNA (0.4-1 mg) was used for liquid scintillation counting.
Animals and treatments.
Isolation of chromatin protein.
One milliliter of the first PCI extract was shaken with 2 ml 1% SDS in 14 mM sodium phosphate pH 6.8. Protein was precipitated with 25 ml acetone, redissolved and reprecipitated five times. Finally, the protein sample was diluted 1:10 with destilled water, precipitated with about two volumes of acetone at -20 ~ C, redissolved in 2 ml 1% SDS, and diluted with water 1 : 10. The amount of protein was determined with the Folin reagent. One milliliter (about 0.5 mg protein) was used for liquid scintillation counting.
Contamination of purified DNA with protein. Two male rats
(250 g) were given by oral gavage 7 mCi/kg L-[3H]lysine. After 4 h, DNA and chromatin protein was isolated via chromatin from the livers. The specific protein activity was 44,100 and 45,200 dpm/mg and the DNA was radiolabelled to give 95.4 and 108 dpm/mg. Nucleoside analysis showed that the natural nucleosides were not radiolabelled.
HPLC analysis of the nucleosides. DNA (1-2 mg/ml) was digested enzymatically by the method described (Sagelsdorff et al. 1983 ). The deoxynacleosides were separated by HPLC with a water to methanol gradient (0-10% in 5 min, 10% for 5 min, 10-100% in 40 min) using a HPLC system consisting of a semipreparative column (250 mm 9 8 mm ID) Lichrosorb RP 18 equipped with two HPLC pumps (Kontron LC pump 410) controlled by a Kontron programmer 200, for generating a linear gradient of two eluants (Kontron, Ztirich, Switzerland). Fractions of 2 min (7 ml) were collected and counted for radioactivity after addition of about 1 ml MeOH to the fractions no. 12-15 to avoid phase separation after addition of Insta-Gel.
HPLC of estrogen metabolites. The supernatant of the first acetone precipitation of chromatin protein from the PCI phase was dried under a stream of nitrogen and dissolved in the same buffer used for DNA. Urine samples were diluted with DNA-buffer to a specific activity of about 1,000 dpm/ml. Reference hormone samples estrone, estradiol, estriol were dissolved in the same buffer. All samples were analyzed by the HPLC system used for the separation of nucleosides.
Control experiments. No. 1. Binding of radiolabelled metabolites to DNA occuring only during the isolation procedure was checked by incubating the supernatant of the first chromatin precipitation (derived from rat No. 3 and 6) with an unlabelled chromatin pellet from a control rat. DNA was then isolated according to method b).
No. 2. Non-enzymatic binding of [3H]estrone to DNA was checked by incubating for 2 h at room temperature 1 mCi hormone with a homogenate of 4 g liver prepared (i) by blending in 25 ml lysing medium and (ii) by the homogenization in 20 ml as used for chromatin precipitation. DNA was isolated (i) directly and (ii) via chromatin, and exhibited a specific activity of 900 and 40 dpm/mg, respectively. The former value was about one hundred times higher than the value reported by Jaggi et al. (1978) from a similar control experiment.
Background radioactivity of DNA and of nucleoside fractions was determined from samples obtained from animals which were held in parallel to the treated ones and which did not receive radiolabelled compounds.
Liquid scintillation counting, calculations and statistics. Samples were counted in Packard high performance glass vials in a Packard rift Carb 460 CD liquid scintillation counter in 10 ml Insta-Gel (Packard Instruments, Downers Grove, IL).
The specific radioactivity of DNA was normalized by the radioactivity dose administered:
CBI' = (dpm/mg DNA)/(dpm/kg body weight).
This value was converted to molar units of the Covalent Binding Index CBI = (~tmol chemical bound/mol DNA-P)/ (mmol chemical applied/kg b.w.) (Lutz 1979) , by multiplication of the CBI' with 309-106 on the basis of an average molecular weight of 309 for a deoxyribonucleotide in DNA.
The limit of detection for radioactivity in a DNA sample was calculated on the level of two standard deviations (SD). One SD was determined to be 0.5 cpm as derived from the standard deviation determined within each of 16 pairs of background counts of DNA isolated from untreated animals (Kaiser 1965) .
The limit of detection for radioactivity in a nucleoside analysis was calculated on the basis of the total variability due to statistical counting error and fluctuations due to vial, scintillation cocktail, counter, external radiation and composition of the sample of each fraction as compiled from five nucleoside analyses of control DNA digests and is shown in the Figures on a level of two SD as a shaded area. Table i summarizes the results obtained for the radioactivity in liver DNA and chromatin protein, 8 h after oral administration of tritiated estrogen hormones to female rats. All liver DNA samples were radiolabelled to an extent which can be called minimal if it is considered that each animal received of the order of 10 mCi of [3H]radiolabel. No difference between Eand Ez-treatment was observable, the mean values for the activity of DNA isolated via chromatin, and expressed after normalization by the dose administered in CBI units, being 0.082 + 0.033 and 0.086 + 0.014 for E and E2, respectively. These values were by a factor of 13 lower than the values published earlier (Jaggi et al. 1978 ) obtained after direct isolation of DNA from liver homogenate. One main difference between the two isolation procedures is the level of protein contamination. The direct DNA isolation as used in the early study yielded a protein contamination of 0.5 % as derived from experiments with [35S]methionine incorporated into protein (Lutz 1979) . DNA isolated via chromatin and use of [3H]lysine as a protein precursor resulted in a value of about 0.2%. Fig. 1 ) 100
Results
Experiments with female rats
Taking into account the relative abundance of methionine or lysine in a protein fraction likely to become a contaminant of DNA, a difference by factors of 2-3 (Table 1 ) and 13 (early vs. present study) are indeed of the same order. Because it is assumed that steroid estrogen hormones exert their hormonal activity on the DNA level via protein receptor binding (Brotherton 1976) , the protein activity could be very high and the protein contamination of DNA could become crucial. The determination of the specific activity of chromatin protein (Table 1 , bottom line) shows that this is the case. Specific activities were 3 9 103 to 3 9 104 times higher in protein than in DNA. DNA radioactivities are therefore most probably due to traces of contaminating protein, and the higher apparent CBI values obtained via direct DNA isolation (Jaggi et al. 1978 ; and data given in Table 1 ) are easily unterstood. Although the protein contamination is reason enough to explain the DNA radioactivity, DNA aliquots were digested enzymatically to nucleosides, and the nucleosides were analyzed by HPLC in a search for potential nucleoside-estrone metabolite adducts (Fig. 1) . Both DNA isolated directly and via chromatin were analysed. The distribution of radioactivity over the elution profile was completely different except for fractions 2 and 5 + 6 which were radiolabelled in both samples. A nucleoside-steroid adduct expected to be more lipophilic than the natural nucleosides and to elute in later fractions could not therefore be located. The radioactivity did not either coelute with the natural nucleosides. This is an indication that no incorporation of tritium from tritiated water or other small radiolabelled breakdown products into DNA had occurred during biosynthesis. The DNA radioactivity must therefore rather be due to contaminations by metabolites and/or contaminating protein present in a qualitatively different way dependent on the method of DNA isolation. In order to verify that radioactivity eluting in fractions 2 and 5 + 6 could be due to metabolites, the organic extract (PCI phase) of chromatin and a diluted urine sample were loaded on the HPLC system. Figure 2 with the respective elution profiles shows that both samples contained radiolabelled material eluting in these early fractions.
Control incubations.
If the DNA radioactivity is primarily a function of protein not completely removed from the DNA, such a non-covalent interaction should also be formed if an unlabelled control chromatin pellet is resuspended in the radioactive supernatant of a chromatin precipitation obtained in a main experiment. The results of this control experiment no. 1 given in Table 1 show that the specific activity of DNA and chromatin protein isolated from the unlabelled control pellet was almost as high as the macromolecules derived from the animals which had been administered E or E2. The specific activity of the control protein was so high after this in vitro incubation that as little as 0.03% contamination on the DNA could fully account for the radioactivity measured in the DNA.
Control experiment no. 2 substantiated the hypothesis that the difference between the specific activity of DNA samples obtained by different isolation procedures is due to different 
Fig. 2. Radioactivity profile (center and bottom)
of HPLC analyses of the organic extract (with PCI) obtained during the isolation of DNA from chromatin (center) and of urine collected from an E-treated female rat. The HPLC system was the same as used for the analysis of enzyme-digested DNA contaminations by non-covalently bound estrogen. There was a 20-fold difference in the specific activity of the DNA purified directly or via chromatin after incubation of liver homogenate with [3H]E, the absolute values being equal to or even higher than those found after treatment of animals if the specific activities are adjusted to the same radioactivity levels in the homogenate.
Additional control experiments not to be reported in detail here have shown that each DNA purification step reduced the specific activity only by a certain factor from non-covalently bound radioactivity so that, for a given procedure and a given compound, the amount of radioactivity present in the homogenate ultimately determines the residual DNA radioactivity.
Experiments with male and female hamsters. The kidney of the male (but not the female) hamster is known to be a target organ for estrogen carcinogenicity (IARC 1979) , If a reactive metabolite is formed in the male hamster kidney able to bind to DNA in substantial amounts, a difference between males and females should be observable. The data. obtained after oral administration of E and E2 are compiled in Tables 2 and 3, respectively. Similarly to the rat, all liver DNA samples were slightly radiolabelled, and there was, again, no difference observable between E and E 2.
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Among the DNA samples isolated from the kidneys, a minute radioactivity was detectable only in the females. Kidney DNA isolated from male hamsters did not contain any measurable radioactivity on a limit of detection of 3.2 dpm per scintillation vial. This finding is in contrast to what could have happened if the susceptibility of the male to tumor induction was reflected by higher DNA binding. The difference between males and females does not go in parallel with the radioactivity present in the whole kidney homogenate. There, the value for the male was two to three times higher than for the female. A working hypothesis to explain this finding will be given in the Discussion section.
Discussion
Our findings make it highly unlikely that a genotoxic activity of estrone and estradiol mediated by DNA binding is a mechanism of tumorigenic activity. The high level of protein-bound radioactivity can easily explain all radioactivity measured on a DNA sample.
The high level of protein binding could be achieved by non-covalent binding to a specific hormone receptor, This protein could in turn bind to specific regions in the DNA (Baskevitch et al. 1983; Brotherton 1976 ) and be the reason for the apparent DNA binding of hormones. In addition, covalent (Bucala et al. 1982; Kappus et al. 1973; Kappus and Bolt 1976; Maggs et al. 1982; Marks and ttecker 1969; Refs. in the Introduction) in the presence of same drug-metabolizing system. The radioactivity isolated vdth these DNA samples can always be attributed to protein contaminations because the data are comparable to our in vitro control incubations if the specific activity of the macromolecules is put into relation to the radioactivity incubated. A more extensive purification of the DNA by CsCI gradient for instance revealed that the radioactivity did not coelute with the eptical density of the DNA band (Duncan and Brookes, 1979) .
Biological test systems for genotoxicity in general produced negative results, for instance in the Ames test (Lang and Redmann 1979) , in mutagenicity tests in mammalian cells (Orevon et al. 1981) , in a DNA repair assay in vitro or alkaline elution test in vivo (Yager and Fifield 1982) or in a test on initiating capabilities in the Solt-Farber system (Schuppler et at. 1983) .
Our data do not exclude a genotoxic mechanism of action in general. Evidence is increasing on the importance of oxygen radicals in tumor initiation and first stage promotion and it is postulated that quinone-hydroquinone oxidation-reduction processes can generate reactive oxygen species able to hydroxylate DNA. This type of indirect genotoxicity goes unobserved if DNA is investigated for bound radiotabelled test c3mpound and it is conceivable that the oxidation of estrone and estradiol to catechol and the corresponding quinone could result in indirect DNA damage. So far, there is no indication that this mechanism of action is operative in the liver. Yager and Fifield (1982) did not detect any DNA damage induced by estrogens either in vivo as assessed by alkaline elution or in primary hepatocyte culture as assessed by DNA repair sicnthesis. Nevertheless, this type of indirect genotoxicity could become particularly important in cells which do not have much estrogen receptor protein but some drug-metabolizing capacity. This situation could be encountered in the male hamster kidney, a target for estrogen carcinogenicity. Possibly because estrogens are bound only weakly to protein in this organ in the male, we were able to isolate a DNA free of radioactivity although the whole-organ radioactivity was even higher than in the females where DNA radioactivity was detectable.
Malignant renal tumors were found in 15 out of 15 male hamsters treated with a 20 mg pellet of E2 subcutaneously every 2t weeks (IARC 1979 ). An average estimated dose of as little as 5 ~tmol/kg/day as used in this treatment therefore led to a 100% tumor incidence. A correlation of tumorigenic potencies and CBI for DNA of the target organ (Lutz 1982) shows that CBI of > 2 10 would be required, if covalent binding to DNA was the mechanism of carcinogenic action. The actual CBI for DNA of the male hamster kidney was < 10 -2. The 10 is an additional indication that discrepancy by a factor of > 4 mechanisms other than DNA binding must be responsible for the respective tumor formation. It must therefore be concluded that DNA binding is an unlikely mechanism of tumorigenic action of estrone or estradiol.
